Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Miltefosine

EU orphan designation number: EU/3/02/104   
Active ingredient: Miltefosine
Indication: Treatment of visceral leishmaniasis
Sponsor: Zentaris GmbH
Weismüllerstrasse 45, D-60314 Frankfurt am Main, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2002 Centralised Orphan - Designation EMEA/OD/072/01 (2002)2227 of 12/06/2002